开云app官网登录入口网页版-官方正版

#高胆固醇血症#

117篇内容 | 3047人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2192120, encodeId=2d7821921203e, content=<a href='/topic/show?id=f70f26896f8' target=_blank style='color:#2F92EE;'>#依折麦布#</a> <a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=关于依折麦布，你至少需要知道这6点！, objectType=article, longId=815761, objectId=2d65815e61a2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021638994_4754896.webp, objectUrl=/article/show_article.do?id=2d65815e61a2, replyNumber=0, likeNumber=63, createdTime=2024-03-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2d65815e61a2, moduleTitle=关于依折麦布，你至少需要知道这6点！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2d65815e61a2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2118071, encodeId=907721180e1dd, content=<a href='/topic/show?id=fe541054e92f' target=_blank style='color:#2F92EE;'>#MK-0616#</a> 由<a href='/topic/show?id=41311033568e' target=_blank style='color:#2F92EE;'>#默克公司#</a>发现和开发，是一种在研的、可能是首个口服 <a href='/topic/show?id=6cdd13883c9' target=_blank style='color:#2F92EE;'>#PCSK9抑制剂#</a>，旨在降低低密度脂蛋白 (LDL) 胆固醇(LDL-C),<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=默沙东口服PCSK9抑制剂IIb期研究成功，显著降低LDL-C, objectType=article, longId=761991, objectId=c1e5e61991db, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230111/e0d311e1e2404269bb9967a4fb4916ba.jpg, objectUrl=/article/show_article.do?id=c1e5e61991db, replyNumber=0, likeNumber=100, createdTime=2023-03-07, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c1e5e61991db, moduleTitle=默沙东口服PCSK9抑制剂IIb期研究成功，显著降低LDL-C, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c1e5e61991db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2090074, encodeId=c74020900e48b, content=该公司在研<a href='/topic/show?id=1e513e666a8' target=_blank style='color:#2F92EE;'>#反义寡核苷酸药物#</a>ION449（AZD8233）能显著降低<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>患者的<a href='/topic/show?id=ada32619472' target=_blank style='color:#2F92EE;'>#低密度脂蛋白胆固醇#</a>（LDL-C）水平，与安慰剂相比，每月皮下注射60mg ION449治疗的患者在28周后，<a href='/topic/show?id=593c10e5975' target=_blank style='color:#2F92EE;'>#LDL-C#</a>水平降低了62.3%。虽然降低LDL-C很多，但是与目前已上市的产品相比，并没有显示出太多的优势，这是不再开发的主要原因，并不代表它没有效！！这种就是良性<a href='/topic/show?id=65c858648d2' target=_blank style='color:#2F92EE;'>#新药研发#</a>状态，不象国内，只要有效就大家一起上，导致越来越卷！, objectTitle=PCSK9反义疗法治疗高胆固醇血症疗效未达预期，阿斯利康终止推向III期, objectType=article, longId=740742, objectId=ff9be4074222, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220915/074d7627c7dc42dc8ed783e69f3a1092.jpg, objectUrl=/article/show_article.do?id=ff9be4074222, replyNumber=0, likeNumber=195, createdTime=2022-09-24, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff9be4074222, moduleTitle=PCSK9反义疗法治疗高胆固醇血症疗效未达预期，阿斯利康终止推向III期, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ff9be4074222)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1380117, encodeId=a778138011e70, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JAMA子刊：“高胆固醇血症”儿童和青少年使用他汀类药物治疗后是否会发生胰岛素抵抗？, objectType=article, longId=739416, objectId=539be394168c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=539be394168c, replyNumber=0, likeNumber=77, createdTime=2022-09-17, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=539be394168c, moduleTitle=JAMA子刊：“高胆固醇血症”儿童和青少年使用他汀类药物治疗后是否会发生胰岛素抵抗？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=539be394168c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380116, encodeId=66971380116ec, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=家族性高胆固醇血症基因治疗药物VERVE-101开始临床试验, objectType=article, longId=738465, objectId=26fce3846538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26fce3846538, replyNumber=0, likeNumber=104, createdTime=2022-09-08, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26fce3846538, moduleTitle=家族性高胆固醇血症基因治疗药物VERVE-101开始临床试验, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=26fce3846538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380115, encodeId=8344138011563, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JAHA：杂合子性家族性高胆固醇血症患者多血管疾病的特征, objectType=article, longId=735014, objectId=711ce3501440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711ce3501440, replyNumber=0, likeNumber=0, createdTime=2022-08-07, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711ce3501440, moduleTitle=JAHA：杂合子性家族性高胆固醇血症患者多血管疾病的特征, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=711ce3501440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380114, encodeId=6a0e13801143f, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JAHA：严重高胆固醇血症的心血管风险和治疗结局, objectType=article, longId=725553, objectId=15c0e255539b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15c0e255539b, replyNumber=0, likeNumber=87, createdTime=2022-04-28, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15c0e255539b, moduleTitle=JAHA：严重高胆固醇血症的心血管风险和治疗结局, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=15c0e255539b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380113, encodeId=e22e1380113f7, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Lancet：全球纯合子家族性高胆固醇血症的诊疗经验, objectType=article, longId=295137, objectId=c84729513ec9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84729513ec9, replyNumber=0, likeNumber=70, createdTime=2022-02-06, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84729513ec9, moduleTitle=Lancet：全球纯合子家族性高胆固醇血症的诊疗经验, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c84729513ec9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380112, encodeId=50f61380112a2, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=EBioMedicine：磁共振成像评估无症状杂合子家族性高胆固醇血症中的心肌纤维化, objectType=article, longId=292174, objectId=95f22921e403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95f22921e403, replyNumber=0, likeNumber=100, createdTime=2021-12-19, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95f22921e403, moduleTitle=EBioMedicine：磁共振成像评估无症状杂合子家族性高胆固醇血症中的心肌纤维化, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=95f22921e403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380111, encodeId=a718138011131, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JCEM：基于EMR的混合诊断模型改进家族性高胆固醇血症的诊断, objectType=article, longId=292142, objectId=b9152921427e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9152921427e, replyNumber=0, likeNumber=70, createdTime=2021-12-19, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9152921427e, moduleTitle=JCEM：基于EMR的混合诊断模型改进家族性高胆固醇血症的诊断, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b9152921427e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380110, encodeId=5cb11380110d9, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JAMA子刊：面对高胆固醇血症，年轻人如何更好降脂？, objectType=article, longId=220863, objectId=3135220863c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3135220863c1, replyNumber=0, likeNumber=105, createdTime=2021-11-24, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3135220863c1, moduleTitle=JAMA子刊：面对高胆固醇血症，年轻人如何更好降脂？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3135220863c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380109, encodeId=105f1380109cf, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Lancet：家族性高胆固醇血症注意了——胆固醇达标可以明显降低心血管危险！, objectType=article, longId=219892, objectId=9d3921989246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d3921989246, replyNumber=0, likeNumber=94, createdTime=2021-11-08, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d3921989246, moduleTitle=Lancet：家族性高胆固醇血症注意了——胆固醇达标可以明显降低心血管危险！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9d3921989246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380108, encodeId=0caf138010810, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Lancet：家族性高胆固醇血症的全球患病率和控制情况, objectType=article, longId=216947, objectId=bd9921694e82, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd9921694e82, replyNumber=0, likeNumber=87, createdTime=2021-09-12, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd9921694e82, moduleTitle=Lancet：家族性高胆固醇血症的全球患病率和控制情况, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bd9921694e82)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380107, encodeId=b6eb138010e4c, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=JACC：双链小干扰RNA Inclisiran可有效降低多种高胆固醇血症患者的低密度脂蛋白胆固醇！, objectType=article, longId=208144, objectId=d3be208144af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3be208144af, replyNumber=0, likeNumber=73, createdTime=2021-03-09, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3be208144af, moduleTitle=JACC：双链小干扰RNA Inclisiran可有效降低多种高胆固醇血症患者的低密度脂蛋白胆固醇！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d3be208144af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380106, encodeId=7163138010678, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=NEJM：Evinacumab 治疗难治性高胆固醇血症, objectType=article, longId=204386, objectId=6349204386b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6349204386b7, replyNumber=0, likeNumber=0, createdTime=2020-12-12, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6349204386b7, moduleTitle=NEJM：Evinacumab 治疗难治性高胆固醇血症, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6349204386b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380105, encodeId=1f931380105f2, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=NEJM：Evinacumab用于纯合子家族性高胆固醇血症的治疗, objectType=article, longId=199745, objectId=27af199e45f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27af199e45f3, replyNumber=0, likeNumber=78, createdTime=2020-08-22, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27af199e45f3, moduleTitle=NEJM：Evinacumab用于纯合子家族性高胆固醇血症的治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=27af199e45f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380104, encodeId=70c01380104cd, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Evinacumab治疗纯合型家族性高胆固醇血症(HoFH)：美国FDA已接受生物许可申请（BLA）, objectType=article, longId=199358, objectId=e53b19935875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e53b19935875, replyNumber=0, likeNumber=93, createdTime=2020-08-15, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e53b19935875, moduleTitle=Evinacumab治疗纯合型家族性高胆固醇血症(HoFH)：美国FDA已接受生物许可申请（BLA）, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e53b19935875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380103, encodeId=5a0f138010320, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=我国4.2%心梗患者有家族性高胆固醇血症！CAMI研究新分析, objectType=article, longId=199246, objectId=570b199246ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=570b199246ae, replyNumber=0, likeNumber=81, createdTime=2020-08-13, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=570b199246ae, moduleTitle=我国4.2%心梗患者有家族性高胆固醇血症！CAMI研究新分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=570b199246ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380102, encodeId=379f138010209, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle= Clinica Chimica Acta：疑似家族性高胆固醇血症患者的冠状动脉疾病和风险相关LPA变异？, objectType=article, longId=199103, objectId=0c52199103bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c52199103bd, replyNumber=0, likeNumber=79, createdTime=2020-08-11, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c52199103bd, moduleTitle= Clinica Chimica Acta：疑似家族性高胆固醇血症患者的冠状动脉疾病和风险相关LPA变异？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0c52199103bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1380101, encodeId=a49c138010175, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, objectTitle=Circulation：家族性高胆固醇血症（FH）的全球发病率, objectType=article, longId=198556, objectId=3499198556d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3499198556d6, replyNumber=0, likeNumber=150, createdTime=2020-08-03, rootId=0, userName=刘阔, userId=d1d1470, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3499198556d6, moduleTitle=Circulation：家族性高胆固醇血症（FH）的全球发病率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3499198556d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

高胆固醇血症

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#依折麦布# #高胆固醇血症#

关于依折麦布，你至少需要知道这6点！

2024-03-08发表于上海

showtest (审核中...)

前往app查看评论内容

#MK-0616# 由#默克公司#发现和开发，是一种在研的、可能是首个口服 #PCSK9抑制剂#，旨在降低低密度脂蛋白 (LDL) 胆固醇(LDL-C),#高胆固醇血症#

默沙东口服PCSK9抑制剂IIb期研究成功，显著降低LDL-C

2023-03-07发表于上海

小小医者 (审核中...)

前往app查看评论内容

全文收起该公司在研#反义寡核苷酸药物#ION449（AZD8233）能显著降低#高胆固醇血症#患者的#低密度脂蛋白胆固醇#（LDL-C）水平，与安慰剂相比，每月皮下注射60mg ION449治疗的患者在28周后，#LDL-C#水平降低了62.3%。虽然降低LDL-C很多，但是与目前已上市的产品相比，并没有显示出太多的优势，这是不再开发的主要原因，并不代表它没有效！！这种就是良性#新药研发#状态，不象国内，只要有效就大家一起上，导致越来越卷！

PCSK9反义疗法治疗高胆固醇血症疗效未达预期，阿斯利康终止推向III期

2022-09-24

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JAMA子刊：“高胆固醇血症”儿童和青少年使用他汀类药物治疗后是否会发生胰岛素抵抗？

2022-09-17

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

家族性高胆固醇血症基因治疗药物VERVE-101开始临床试验

2022-09-08

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JAHA：杂合子性家族性高胆固醇血症患者多血管疾病的特征

2022-08-07

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JAHA：严重高胆固醇血症的心血管风险和治疗结局

2022-04-28

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Lancet：全球纯合子家族性高胆固醇血症的诊疗经验

2022-02-06

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

EBioMedicine：磁共振成像评估无症状杂合子家族性高胆固醇血症中的心肌纤维化

2021-12-19

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JCEM：基于EMR的混合诊断模型改进家族性高胆固醇血症的诊断

2021-12-19

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JAMA子刊：面对高胆固醇血症，年轻人如何更好降脂？

2021-11-24

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Lancet：家族性高胆固醇血症注意了——胆固醇达标可以明显降低心血管危险！

2021-11-08

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Lancet：家族性高胆固醇血症的全球患病率和控制情况

2021-09-12

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

JACC：双链小干扰RNA Inclisiran可有效降低多种高胆固醇血症患者的低密度脂蛋白胆固醇！

2021-03-09

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

NEJM：Evinacumab 治疗难治性高胆固醇血症

2020-12-12

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

NEJM：Evinacumab用于纯合子家族性高胆固醇血症的治疗

2020-08-22

智慧医人 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Evinacumab治疗纯合型家族性高胆固醇血症(HoFH)：美国FDA已接受生物许可申请（BLA）

2020-08-15

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

我国4.2%心梗患者有家族性高胆固醇血症！CAMI研究新分析

2020-08-13

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Clinica Chimica Acta：疑似家族性高胆固醇血症患者的冠状动脉疾病和风险相关LPA变异？

2020-08-11

刘阔 (审核中...)

前往app查看评论内容

#高胆固醇血症#

Circulation：家族性高胆固醇血症（FH）的全球发病率

2020-08-03

科室
- - 订阅+
  - 更多科室
工具
服务